Preventing Microalbuminuria in Type 2 Diabetes

In a multicenter, double-blind, placebo-controlled, randomized study, subjects with type 2 diabetes mellitus and hypertension but normal urinary albumin levels were treated with an angiotensin-converting–enzyme (ACE) inhibitor (trandolapril) and a non-dihydropyridine calcium-channel blocker (verapam...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2004-11, Vol.351 (19), p.1941-1951
Hauptverfasser:	Ruggenenti, Piero, Fassi, Anna, Ilieva, Anelja Parvanova, Bruno, Simona, Iliev, Ilian Petrov, Brusegan, Varusca, Rubis, Nadia, Gherardi, Giulia, Arnoldi, Federica, Ganeva, Maria, Ene-Iordache, Bogdan, Gaspari, Flavio, Perna, Annalisa, Bossi, Antonio, Trevisan, Roberto, Dodesini, Alessandro R, Remuzzi, Giuseppe
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Albuminuria - prevention & control Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive Agents - therapeutic use Biological and medical sciences Blood pressure Calcium Channel Blockers - therapeutic use Diabetes Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Disease Progression Double-Blind Method Drug Therapy, Combination Female General aspects Heart attacks Humans Hypertension Hypertension - complications Hypertension - drug therapy Indoles - therapeutic use Male Medical sciences Middle Aged Nephrology. Urinary tract diseases Proportional Hazards Models Statistical analysis Treatment Outcome Urinary system involvement in other diseases. Miscellaneous Urinary tract. Prostate gland Verapamil - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!